News and Analysis

Pulmonx reels in $66m

Silicon Valley-based Pulmonx, a provider of minimally-invasive treatment for patients with severe emphysema, has secured $66 million in funding.

-

Silicon Valley-based Pulmonx, a provider of minimally-invasive treatment for patients with severe emphysema, has secured $66 million in funding. Ally Bridge Capital led the round.

Source: Press Release